- Patent Title: MicroRNAs expression signature for determination of tumors origin
-
Application No.: US14284256Application Date: 2014-05-21
-
Publication No.: US09803247B2Publication Date: 2017-10-31
- Inventor: Nitzan Rosenfeld , Shai Rosenwald , Iris Barshack , Dvora Nass
- Applicant: Rosetta Genomics Ltd. , Tel Hashomer Medical Research Infrastructure and Services Ltd.
- Applicant Address: IL Rehovot IL Ramat Gan
- Assignee: Rosetta Genomics, Ltd.,Tel Hashomer Medical Infrastructure and Services Ltd.
- Current Assignee: Rosetta Genomics, Ltd.,Tel Hashomer Medical Infrastructure and Services Ltd.
- Current Assignee Address: IL Rehovot IL Ramat Gan
- Agency: Polsinelli PC
- Agent Ron Galant
- Main IPC: C12Q1/68
- IPC: C12Q1/68
Abstract:
The present invention provides a process for classification of specific cancers and tumors origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
Public/Granted literature
- US20160115546A1 MICRORNAS EXPRESSION SIGNATURE FOR DETERMINATION OF TUMORS ORIGIN Public/Granted day:2016-04-28
Information query
